Chronisch thromboembolische pulmonale Hypertonie

Die chronisch thromboembolische pulmonale Hypertonie (CTEPH) ist eine seltene Erkrankung, aber gut behandelbare Spätfolge nach einer akuten Lungenembolie. Daher wird eine Nachuntersuchung nach einer ausreichenden Antikoagulation von mindestens 3 Monaten empfohlen. Es stehen 3 Behandlungsmethoden zur Verfügung: die pulmonale Endarteriektomie, die pulmonale Ballonangioplastie und Medikamente, die auf die pulmonale Hypertonie wirken. Die Entscheidung über die Behandlung sollte von einem erfahrenen multidisziplinären Team in spezialisierten CTEPH-Zentren getroffen werden.

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease, but an important late sequela after acute pulmonary embolism. Therefore, follow-up after at least three months of sufficient anticoagulation is recommended. Patients with suspected CTEPH should be referred to specialized CTEPH centers for further evaluation and treatment.

Three treatment modalities are available: pulmonary endarterectomy (PEA), balloon pulmonary angioplasty (BPA) and pulmonary hypertension-targeted drugs. The indication for surgery depends mainly on the localization of the pulmonary arterial obstructions. Severe comorbidities as well as advanced age need individual evaluation, but do not present strict exclusion criteria. Multimodal treatments are common practice in inoperable CTEPH. However, treatment decision making in an experienced multidisciplinary team is mandatory.

Kernaussagen

• CTEPH ist eine wichtige Komplikation nach überstandener Lungenembolie.

• Diagnostik und Therapie der CTEPH sollten in entsprechend spezialisierten Zentren erfolgen.

• Es gibt 3 etablierte Therapiemodalitäten: die pulmonale Endarteriektomie, die medikamentöse Therapie und die pulmonale Ballonangioplastie.

• Das therapeutische Konzept hängt maßgeblich von der Lokalisation der pulmonalarteriellen Obstruktionen und der pulmonalen Hämodynamik ab.

• Patienten mit CTEPH sollen langfristig (mindestens jährlich) verlaufskontrolliert werden.

Schlüsselwörter

CTEPH - CTEPD - pulmonale Hypertonie - PEA - BPA

Keywords

CTEPH - CTEPD - pulmonary hypertension - PEA - BPA

Publication History

Article published online:
10 November 2023

• Literatur

• 1 Pepke-Zaba J, Delcroix M, Lang I. et al. Chronic thromboembolic pulmonary hypertension (CTEPH): Results from an international prospective registry. Circulation 2011; 124: 1973-1981 DOI: 10.1161/CIRCULATIONAHA.110.015008.
• 2 Simonneau G, Torbicki A, Dorfmüller P. et al. The pathophysiology of chronic thromboembolic pulmonary hypertension. Eur Respir Rev 2017; 26: 160112 DOI: 10.1183/16000617.0112-2016. (PMID: 28356405)
• 3 Humbert M, Kovacs G, Hoeper MM. et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2023; 61: 2200879 DOI: 10.1183/13993003.00879-2022. (PMID: 36017548)
• 4 Quadery SR, Swift AJ, Billings CG. et al. The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension. Eur Respir J 2018; 52: 1800589 DOI: 10.1183/13993003.00589-2018. (PMID: 30002102)
• 5 Delcroix M, Torbicki A, Gopalan D. et al. ERS statement on chronic thromboembolic pulmonary hypertension. Eur Respir J 2021; 57: 2002828 DOI: 10.1183/13993003.02828-2020. (PMID: 33334946)
• 6 Ende-Verhaar YM, Cannegieter SC, Noordegraaf AV. et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: A contemporary view of the published literature. Eur Respir J 2017; 49: 1601792 DOI: 10.1183/13993003.01792-2016.
• 7 Kramm T, Wilkens H, Fuge J. et al. Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany. Clin Res Cardiol 2018; 107: 548-553 DOI: 10.1007/s00392-018-1215-5. (PMID: 29450722)
• 8 Held M, Pfeuffer-Jovic E, Wilkens H. et al. Frequency and characterization of CTEPH and CTEPD according to the mPAP threshold > 20 mm Hg: Retrospective analysis from data of a prospective PE aftercare program. Respir Med 2023; 210: 107177 DOI: 10.1016/j.rmed.2023.107177.
• 9 Boon GJAM, Ende-Verhaar YM, Beenen LFM. et al. Prediction of chronic thromboembolic pulmonary hypertension with standardised evaluation of initial computed tomography pulmonary angiography performed for suspected acute pulmonary embolism. Eur Radiol 2022; 32: 2178-2187 DOI: 10.1007/s00330-021-08364-0.
• 10 Valerio L, Mavromanoli AC, Barco S. et al. Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study. Eur Heart J 2022; 43: 3387-3398 DOI: 10.1093/eurheartj/ehac206. (PMID: 35484821)
• 11 Bonderman D, Wilkens H, Wakounig S. et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 2009; 33: 325-331 DOI: 10.1183/09031936.00087608. (PMID: 18799507)
• 12 Simonneau G, Dorfmüller P, Guignabert C. et al. Chronic thromboembolic pulmonary hypertension: the magic of pathophysiology. Ann Cardiothorac Surg 2022; 11: 106-119 DOI: 10.21037/acs-2021-pte-10. (PMID: 35433354)
• 13 Viswanathan G, Kirshner HF, Nazo N. et al. Single-Cell Analysis Reveals Distinct Immune and Smooth Muscle Cell Populations that Contribute to Chronic Thromboembolic Pulmonary Hypertension. Am J Respir Crit Care Med 2023; 207: 1358-1375 DOI: 10.1164/rccm.202203-0441OC.
• 14 Konstantinides SV, Meyer G, Becattini C. et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020; 41: 543-603 DOI: 10.1093/eurheartj/ehz405.
• 15 Masy M, Giordano J, Petyt G. et al. Dual-energy CT (DECT) lung perfusion in pulmonary hypertension: concordance rate with V/Q scintigraphy in diagnosing chronic thromboembolic pulmonary hypertension (CTEPH). Eur Radiol 2018; 28: 5100-5110 DOI: 10.1007/s00330-018-5467-2.
• 16 de Perrot M, Gopalan D, Jenkins D. et al. Evaluation and management of patients with chronic thromboembolic pulmonary hypertension – consensus statement from the ISHLT. J Heart Lung Transplant 2021; 40: 1301-1326 DOI: 10.1016/j.healun.2021.07.020.
• 17 Wiedenroth CB, Bandorski D, Ariobi K. et al. Does Age Matter? Pulmonary Endarterectomy in the Elderly Patient with CTEPH. Thorac Cardiovasc Surg 2022; 70: 663-670 DOI: 10.1055/s-0041-1740559.
• 18 Humbert M, Simonneau G, Pittrow D. et al. Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant 2022; 41: 716-721 DOI: 10.1016/j.healun.2022.02.002. (PMID: 35305871)
• 19 Pengo V, Denas G, Zoppellaro G. et al. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood 2018; 132: 1365-1371 DOI: 10.1182/blood-2018-04-848333.
• 20 Nagel C, Prange F, Guth S. et al. Exercise Training Improves Exercise Capacity and Quality of Life in Patients with Inoperable or Residual Chronic Thromboembolic Pulmonary Hypertension. PLoS One 2012; 7: e41603 DOI: 10.1371/journal.pone.0041603. (PMID: 22848542)
• 21 Kim NH, Delcroix M, Jaïs X. et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2019; 53: 1801915 DOI: 10.1183/13993003.01915-2018. (PMID: 30545969)
• 22 Lankeit M, Krieg V, Hobohm L. et al. Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant 2018; 37: 250-258 DOI: 10.1016/j.healun.2017.06.011. (PMID: 28750932)
• 23 Delcroix M, Lang I, Pepke-Zaba J. et al. Long-Term Outcome of Patients with Chronic Thromboembolic Pulmonary Hypertension: Results from an International Prospective Registry. Circulation 2016; 133: 859-871 DOI: 10.1161/CIRCULATIONAHA.115.016522.
• 24 Ghofrani HA, D’Armini AM, Grimminger F. et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 2013; 369: 319-329 DOI: 10.1056/NEJMoa1209657. (PMID: 23883377)
• 25 Guth S, D’Armini AM, Delcroix M. et al. Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry. ERJ Open Res 2021; 7: 00850-02020 DOI: 10.1183/23120541.00850-2020. (PMID: 34409094)
• 26 Brenot P, Jaïs X, Taniguchi Y. et al. French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Eur Respir J 2019; 53: 1802095 DOI: 10.1183/13993003.02095-2018. (PMID: 31023842)
• 27 Olsson KM, Wiedenroth CB, Kamp JC. et al. Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience. Eur Respir J 2017; 49: 1602409 DOI: 10.1183/13993003.02409-2016.
• 28 Darocha S, Araszkiewicz A, Kurzyna M. et al. Balloon Pulmonary Angioplasty in Technically Operable and Technically Inoperable Chronic Thromboembolic Pulmonary Hypertension. J Clin Med 2021; 10: 1038 DOI: 10.3390/jcm10051038. (PMID: 33802475)
• 29 Wiedenroth CB, Rolf A, Steinhaus K. et al. Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary Hypertension. J Heart Lung Transplant 2023; 42: 134-139 DOI: 10.1016/j.healun.2022.08.011.
• 30 Jaïs X, Brenot P, Bouvaist H. et al. Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study. Lancet Respir Med 2022; 10: 961-971 DOI: 10.1016/S2213-2600(22)00214-4. (PMID: 35926542)
• 31 Cannon JE, Su L, Kiely DG. et al. Dynamic risk stratification of patient long-term outcome after pulmonary Endarterectomy: Results from the United Kingdom national cohort. Circulation 2016; 133: 1761-1771 DOI: 10.1161/CIRCULATIONAHA.115.019470.
• 32 Araszkiewicz A, Darocha S, Pietrasik A. et al. Balloon pulmonary angioplasty for the treatment of residual or recurrent pulmonary hypertension after pulmonary endarterectomy. Int J Cardiol 2019; 278: 232-237 DOI: 10.1016/j.ijcard.2018.10.066. (PMID: 30409735)
• 33 Wiedenroth CB, Liebetrau C, Breithecker A. et al. Combined pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. J Heart Lung Transplantat 2016; 35: 591-596 DOI: 10.1016/j.healun.2015.10.030.
• 34 Mayer E, Jenkins D, Lindner J. et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registry. J Thorac Cardiovasc Surg 2011; 141: 702-710 DOI: 10.1016/j.jtcvs.2010.11.024.